NEW YORK (GenomeWeb) – Emory University's School of Medicine and global testing firm Eurofins Scientific today announced they have entered into an agreement whereby Eurofins will acquire a controlling interest in the Emory Genetics Laboratory (EGL).

EGL is a part of the Department of Human Genetics and provides testing services for hospitals and other institutional clients. It specializes in next-generation sequencing testing, especially for rare genetic disorders, the university said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.